CCI vs PTCT · P/E 40, rev $6.57B vs rev $806.8M
Crown Castle (CCI) versus PTC Therapeutics Inc (PTCT) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported PTCT revenue for 2024-12-31 was $806.8M. Net income was -$363.3M. Revenue was down 14.0% from 2023-12-31 to 2024-12-31. PTCT currently screens at market cap $6.51B.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. PTCT currently screens at market cap $6.51B.
Not investment advice. Open the CCI and PTCT stock pages for the full models.
Not investment advice.